Cargando…

The Role of p53 Family in Cancer

Detalles Bibliográficos
Autor principal:	Zawacka-Pankau, Joanna E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833922/ https://www.ncbi.nlm.nih.gov/pubmed/35159090 http://dx.doi.org/10.3390/cancers14030823

Ejemplares similares

The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy-Drug Repurposing
por: Zawacka-Pankau, Joanna E.
Publicado: (2020)

The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
por: Fregni, Matilde, et al.
Publicado: (2022)

The p53/MDM2/MDMX-targeted therapies—a clinical synopsis
por: Jiang, Liren, et al.
Publicado: (2020)

Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
por: Jiang, Liren, et al.
Publicado: (2019)

Activation of TAp73 and inhibition of TrxR by Verteporfin for improved cancer therapy in TP53 mutant pancreatic tumors
por: Acedo, Pilar, et al.
Publicado: (2019)

APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2018)

Correction: APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
por: Zhang, Qiang, et al.
Publicado: (2019)

The Changes in the p53 Protein across the Animal Kingdom Point to Its Involvement in Longevity
por: Bartas, Martin, et al.
Publicado: (2021)

The use of ion mobility mass spectrometry to probe modulation of the structure of p53 and of MDM2 by small molecule inhibitors
por: Dickinson, Eleanor R., et al.
Publicado: (2015)

Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells
por: Sznarkowska, Alicja, et al.
Publicado: (2018)

Correction to: Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells
por: Sznarkowska, Alicja, et al.
Publicado: (2019)

Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule
por: Grinkevich, Vera V., et al.
Publicado: (2022)

ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis
por: Shi, Y, et al.
Publicado: (2014)

p53 and aging: role of p66Shc
por: Migliaccio, Enrica, et al.
Publicado: (2013)

p53 Signaling in Cancers
por: Issaeva, Natalia
Publicado: (2019)

Targeting mutant p53 for cancer therapy
por: Oren, Moshe, et al.
Publicado: (2016)

p53 Family: Role of Protein Isoforms in Human Cancer
por: Wei, Jinxiong, et al.
Publicado: (2012)

Δ113p53/Δ133p53: survival and integrity
por: Chen, Jun, et al.
Publicado: (2015)

The p53 family and VEGF regulation: “It’s complicated”
por: Farhang Ghahremani, Morvarid, et al.
Publicado: (2013)

Alchemix, p53 and topoisomerase
por: Grand, Roger J, et al.
Publicado: (2015)

Recent Advances in p53
por: D’Orazi, Gabriella
Publicado: (2021)

Role of p53 Family Proteins in Metformin Anti-Cancer Activities
por: Yi, Yong, et al.
Publicado: (2019)

p53 pathway dysfunction in AML: beyond TP53 mutations
por: Post, Sean M., et al.
Publicado: (2017)

Selective targeting of p53 gain-of-function mutants in cancer
por: Padmanabhan, Achuth
Publicado: (2018)

Regulation of p53 by Helicobacter pylori
por: Zaika, Alexander, et al.
Publicado: (2012)

Simplify p53: just an activator
por: Engeland, Kurt
Publicado: (2014)

p53-induced autophagy and senescence
por: Sui, Xinbing, et al.
Publicado: (2015)

Chromatin dysregulation by mutant p53
por: Pfister, Neil T., et al.
Publicado: (2016)

Flipping the “switch” on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer
por: Yu, Xin, et al.
Publicado: (2019)

New potential instrument to fight hepatocellular cancer by restoring p53
por: Vincent, Franklin C., et al.
Publicado: (2011)

Have the roles of two functional polymorphisms in breast cancer, R72P in P53 and MDM2-309 in MDM2, become clearer?
por: Scott, Rodney J
Publicado: (2010)

The Competition of Yin and Yang: Exploring the Role of Wild-Type and Mutant p53 in Tumor Progression
por: Cai, Bi-He, et al.
Publicado: (2023)

The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer
por: Napoli, Marco, et al.
Publicado: (2020)

p53: Pro-aging or pro-longevity?
por: de Keizer*, Peter L.J., et al.
Publicado: (2010)

p53 further extends its reach
por: Zirngibl, Katharina, et al.
Publicado: (2013)

p53 as a target in myeloproliferative neoplasms
por: Lu, Min, et al.
Publicado: (2012)

P53 in lung vascular barrier dysfunction
por: Barabutis, Nektarios
Publicado: (2020)

Understanding and Therapeutic Targeting of the p53 Network
por: Bacher, Susanne, et al.
Publicado: (2023)

Emerging Roles of p53 Family Members in Glucose Metabolism
por: Itahana, Yoko, et al.
Publicado: (2018)

The p53 Family: A Role in Lipid and Iron Metabolism
por: Laubach, Kyra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mnsoeqetjfs8p12r1ciddu3le2